When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.

Mark Zuckerberg and Priscilla Chan’s Biohub is investing $500 million to build AI models of human cells, as tech giants race ...

In the open ocean, far from coasts and categories, there is a fish that seems to defy the logic of design. It is round where ...

The molecular biosciences form the bedrock of modern life science innovation, driving progress in synthetic biology, systems biology, genetics, ...

Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...

Human babies arrive with 100 extra bones for the same reason birth is the most dangerous event in mammalian life. Both facts ...

The rapid advances in machine learning (ML) and artificial intelligence (AI) are transforming biology and opening new directions for scientific inquiry.

Venter led the private effort to sequence the human genome and created the first synthetic bacterial cell while launching ...

Scientists shared transcripts with The Times in which chatbots described how to assemble deadly pathogens and unleash them in ...

An engineered E. coli strain survived after one amino acid was designed out of many of its ribosomal proteins—an early test ...

Recent advances in AI, from AlphaFold to generative models, are reshaping protein design, enabling scientists to create novel proteins with precise functions. Researchers are now developing proteins ...

Brenig Therapeutics Inc. (Brenig), a clinical-stage biotechnology company advancing best-in-class therapies for neurodegenerative, neuroinflammatory, and cardiometabolic diseases, today announced that ...